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Tubular aggregates are regular arrays of membrane tubules accumulating in muscle with age. They are found as secondary features in
several muscle disorders, including alcohol- and drug-induced myopathies, exercise-induced cramps, and inherited myasthenia, but
also exist as a pure genetic form characterized by slowly progressive muscle weakness. We identified dominant STIM1 mutations as
a genetic cause of tubular-aggregatemyopathy (TAM). Stromal interactionmolecule 1 (STIM1) is themainCa2þ sensor in the endoplasmic
reticulum, and all mutations were found in the highly conserved intraluminal Ca2þ-binding EF hands. Ca2þ stores are refilled through
a process called store-operated Ca2þ entry (SOCE). Upon Ca2þ-store depletion, wild-type STIM1 oligomerizes and thereby triggers extra-
cellular Ca2þ entry. In contrast, the missense mutations found in our four TAM-affected families induced constitutive STIM1 clustering,
indicating that Ca2þ sensing was impaired. By monitoring the calcium response of TAM myoblasts to SOCE, we found a significantly
higher basal Ca2þ level in TAMcells and a dysregulation of intracellular Ca2þhomeostasis. Because recessive STIM1 loss-of-functionmuta-
tions were associated with immunodeficiency, we conclude that the tissue-specific impact of STIM1 loss or constitutive activation is
different and that a tight regulation of STIM1-dependent SOCE is fundamental for normal skeletal-muscle structure and function.Ca2þ is a major regulatory and signaling molecule in skel-
etal muscle; therefore, the cellular Ca2þ dynamics need to
be tightly regulated. Intracellular Ca2þ is mainly stored in
the sarcoplasmic reticulum (SR) and, upon stimulation, is
released to the cytoplasm, where it triggers muscle contrac-
tion and acts as a second messenger controlling growth
and differentiation. Ca2þ stores are refilled through store-
operated Ca2þ entry (SOCE). Stromal interaction molecule
1 (STIM1) is the main Ca2þ sensor on the endoplasmic
reticulum (ER). It contains an intraluminal region with
two EF hands and a sterile a-motif domain (SAM), a single
transmembrane domain, and a cytosolic part interacting
with other proteins.1,2 The EF hands sense and bind Ca2þ,
and in the bound state, the EF hands and the SAM
domain are in steric proximity. When Ca2þ is unbound
as a result of store depletion, STIM1 unfolds and oligomer-
izes through its SAM domains.2,3 The oligomerization
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In this paper, we describe four families affected by domi-
nant tubular-aggregate myopathy (TAM [MIM 160565]),
which is characterized by regular arrays of membrane
tubules on muscle biopsies without additional histopatho-
logical hallmarks (Table 1 and Table S1, available online).
Apart from this ‘‘pure’’ form, tubular aggregates can also
be found as secondary features in a variety of muscle
disorders, including alcohol- and drug-induced myopa-
thies, exercise-induced cramps or muscle weakness, and
inherited myopathies and myasthenia.8,9 In our TAM-
affected families, disease onset was during childhood (indi-
viduals II.1 and II.2 from family 1, II.10 from family 2, and
I.2 and II.2 from family 3), adolescence (I.1 from family 1
and II.2 from family 2), or early adulthood (III.1 from
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Table 1. Molecular, Phenotypic, and Histopathological Data of Individuals with Dominant STIM1 Mutations
Family 1 Family 2 Family 3 Family 4
I.1 II.1 II.2 II.2 II.10 III.1 I.2 II.2 I.2 II.1 II.2
Gender female male male female male female male male male male male
Mutation c.251A>G c.251A>G c.251A>G c.325C>A c.325C>A c.325C>A c.326A>G c.326A>G c.216C>G c.216C>G c.216C>G
Predicted
protein impact
p.Asp84Gly p.Asp84Gly p.Asp84Gly p.His109Asn p.His109Asn p.His109Asn p.His109Arg p.His109Arg p.His72Gln p.His72Gln p.His72Gln
Onset adolescence childhood childhood adolescence childhood adulthood childhood childhood asymptomatic asymptomatic asymptomatic
Age at last
examination
(years)
61 54 49 68 51 41 57 33 59 30 24
Muscle
weakness
lower limbs
proximal
lower limbs
proximal,
upper limbs
mild and
diffuse
lower limbs
proximal
lower limbs
proximal
lower limbs
proximal
lower limbs
proximal,
upper limbs
mild and
proximal
severe, upper
and lower limbs,
predominantly
proximal
lower limbs
proximal,
upper limbs
mild and
proximal
no no no
Eye-movement
defects
mild upward-
gaze paresis
mild upward-
and lateral-
gaze paresis
upward-gaze
paresis
no no no ophthalmoplegia,
upward-gaze
paresis
ophthalmoplegia,
upward-gaze
paresis
no no no
Contractures no heels, wrists,
fingers
heels, wrists,
fingers
no knees heels severe, neck,
elbows, wrists,
fingers
neck, heels no no no
CK levels elevated 83 elevated 43 elevated 43 elevated 53 elevated 73 elevated 53 elevated 123 elevated 53 elevated 273 elevated 93 elevated
Tubular-aggregate
classification
ND in type I and II
fibers, VMC
and IC
ND in type I and II
fibers, VMC
and IC
in type I and II
fibers, VMC
and IC
mainly in
type I fibers,
VMC and IC
mainly in type I
fibers, VMC
and IC
in type I and II
fibers, VMC
and IC
in type I and II
fibers, VMC
and IC
in type I and II
fibers, VMC
and IC
in type I and II
fibers, VMC
and IC
Specific
histological
features
ND fiber size
variation,
type I fiber
predominance
ND type II fiber
atrophy
type II fiber
atrophy
type II fiber
atrophy
type I fiber
predominance,
type II fiber
atrophy
type I fiber
predominance,
type II fiber
atrophy
fiber size
variation,
type I fiber
predominance,
type II fiber
atrophy
fiber size
variation,
type I fiber
predominance,
type II fiber
atrophy
fiber size
variation,
type I fiber
predominance,
type II fiber
atrophy
The following abbreviations are used: CK, creatine kinase; ND, not determined; VMC, vesicular membrane collection (according to Chevessier et al.8); and IC, tubular aggregates with empty or moderately dense flocculent
material.
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Figure 1. Characterization of Tubular
Aggregates in Skeletal Muscle
Histology, immunofluorescence, and elec-
tron microscopy of muscle biopsies
from affected individuals II.1 (family 1,
p.Asp84Gly) and III.1 (family 2,
p.His109Asn).
(A) Histological analysis of transverse
sections (10 mm) revealed aggregations on
modified Gomori trichrome and NADH-
TR staining, but not on succinic-dehydro-
genase (SDH) staining (II.1, family 1).
(B) Ultrastructural analysis demonstrated
prominent tubular aggregation with
single- or double-walled membranes on
transversal (II.1, family 1) and longitudinal
(III.1, family 2) sections.
(C) Immunofluorescence showed colocali-
zation of STIM1 and RYR1 in the periphery
of the aggregates, whereas SERCA1 homo-
geneously labeled the aggregates (II.1,
family 1). The upper panel shows muscle
sections of a healthy individual.Ophthalmoparesis without ptosis was mild in family 1 and
severe in family 3, and contractures of the elbows, wrist
and fingers, heel cords, and neck were reported for both
families. Individual II.1 from family 1 had a 1-week-long
paresis of the lower limbs at age 9, and III.1 from family
2 had a period of worsening and moderate variability. No
cardiac involvement was reported, and breathing was
normal except for family 3member I.2, who required inter-
mittent nocturnal ventilation. At the last medical exami-
nation, all affected individuals except I.2 from family 3
were ambulant. The three TAM-affected individuals from
family 4 were asymptomatic, although needle electromy-
ography using quantitative analysis of 20 motor unit
potentials revealed a slight myopathic pattern in II.1
(Figure S1). This might be related to the specific mutation
or to the fact that these persons underwent regular andThe American Journal of Human Gestrong physical training as a part of
their military duties. The muscle
disorder was detected through
routine creatine-kinase (CK) blood
tests. CK levels were strongly elevated
in affected individuals from all fami-
lies, and electrophysiological analyses
revealed a myopathic pattern in all
tested individuals (there was no
decrement at testing).
Muscle biopsies of the affected indi-
viduals displayed predominantly type
II fiber atrophy (Figures S2 and S3);
aggregates appeared in red on Gomori
trichrome and in dark blue on NADH-
TR staining (Figure 1A and Figure S3).
The aggregates were absent with suc-
cinic-dehydrogenase (SDH) staining,
indicating a reticular, but not mito-
chondrial, origin.10,11 Ultrastructuralanalysis demonstrated massive tubular aggregation and
single- or double-walled membranes of different diameters
(Figure 1B). Tubular aggregates originate from the SR,8,10,11
but the exact mechanisms leading to their formation in
skeletal muscle fibers are elusive.12 We have previously
shown that different proteins involved in the uptake and
storage of calcium, such as SERCA1, sarcalumenin, or tria-
din, are components of the aggregates.8 Here, we demon-
strated by immunohistofluorescence using antibodies
against markers of the SR that SERCA1 and triadin strongly
label the aggregates, whereas RYR1 and STIM1 localize in
their periphery (Figure 1C and Figures S4 and S5). This
might be linked to the fact that SERCA1 and triadin
localize at the longitudinal SR, whereas RYR1 and STIM1
localize at the junctional SR, suggesting the presence of
triads at the periphery of the aggregates as documentednetics 92, 271–278, February 7, 2013 273
Figure 2. Identification of STIM1 Muta-
tions in Autosomal-Dominant TAM
(A) Pedigrees indicate dominant inheri-
tance of TAM, and sequence analysis
confirmed the segregation of the heterozy-
gous mutations with the disease.
(B) Schematic representation of the STIM1
domains. Arrows indicate the position of
the substitutions in the EF-hand domains
(amino acids 63–128). The following
abbreviations are used: TM , transmem-
brane domain; CC, coiled-coil domain; SP,
serine- and proline-rich domain; and K,
polylysine.
(C) Protein-sequence conservation of the
STIM1 EF hands. The affected amino acids
are highly conserved.
(D) The resolved protein structure demon-
strates a close proximity of the affected
amino acids to the Ca2þ-binding domain.
(E) Immunoblot of endogenous STIM1 in
individual II.1 from family 1 and control
myoblasts shows a comparable STIM1 level.
b-Tubulin was used as a loading control.by electron microscopy.8,9 Tubular aggregates were mainly
reported in males from recessive families or simplex cases
and were most often found only in type II fibers.12 In
contrast, in this study, we describe autosomal-dominant
TAM-affected families involving both genders and both
types of muscle fibers. This strongly suggests that different
genes are implicated in the dominant and recessive TAM
forms.
In order to identify the genetic cause of dominant TAM,
we performed exome sequencing of all four members of
family 1 by using the Agilent SureSelect Human All Exon
Kit and the Illumina Genome Analyzer IIx to generate
72 nt single reads. Sample collection was performed with
informed consent from the affected individuals according
to the declaration of Helsinki, and the protocols were
validated by the Comite´ de Protection des Personnes
Est IV. Sequence data were aligned to the reference
genome GRCh37/hg19 with the use of the Burrows-
Wheeler Aligner13 and were processed with SAMtools.14
We identified a heterozygous c.251A>G (p.Asp84Gly)
missense mutation in STIM1 (MIM 605921) (Table 1 and274 The American Journal of Human Genetics 92, 271–278, February 7, 2013Figure 2). This mutation was present
in all affected members and absent
in the unaffected members, confirm-
ing autosomal-dominant inheritance.
By Sanger sequencing of all STIM1
coding exons and exon-intron bound-
aries in families with similar histolog-
ical findings or by exome sequencing
of two affected individuals from
family 4, we found three additional
STIM1 heterozygous missense muta-
tions segregating with the disease
(Figure 2A). The mutations were
numbered according to RefSeq acces-sion number NM_003156.3 and GenBank accession
numberAAH21300.1, andnonewere listed in the SNPdata-
bases (dbSNP and 1000 Genomes) or in the National Heart,
Lung, and Blood Institute (NHLBI) Exome Variant Server.
The impact of variations were predicted with SIFT15 and
PolyPhen.16 All four mutations, c.216C>G (p.His72Gln),
c.251A>G (p.Asp84Gly), c.325C>A (p.His109Asn), and
c.326A>G (p.His109Arg), cluster in the EF hands and affect
highly conserved amino acids (Figures 2B and 2C). The
resolved protein structure2 revealed a close proximity
of the affected residues (Figure 2D). The level of STIM1
was not decreased in myoblasts from individual II.1 in
family 1 (Figure 2E).
Mutations in the EF hands are thought to disrupt Ca2þ
binding and/or destabilize the interaction with the SAM
domain,17–19 unfold a hydrophobic cleft, and induce
STIM1 oligomerization.2 To assess the impact and the
pathological significance of the identified mutations,
we transfected C2C12 myoblasts with wild-type or altered
STIM1 yellow-fluorescent-protein (YFP) constructs. Thap-
sigargin inhibits SERCA1 and induces SR Ca2þ depletion,
Figure 3. STIM1 Clustering in C2C12
Cells in Dependence of Thapsigargin and
Quantification
(A) C2C12 myoblasts were transfected
with wild-type or altered STIM1 YFP
constructs with the use of Lipofectamine
2000 (Invitrogen, Carlsbad, CA, USA)
andwere incubatedwith orwithout thapsi-
gargin (2 mM; Sigma-Aldrich, St. Louis,
MO, USA). Point mutations c.216C>G
(p.His72Gln), c.251A>G (p.Asp84Gly),
c.325C>A (p.His109Asn), and c.326A>G
(p.His109Arg) were introduced by site-
directed mutagenesis with the Pfu DNA
polymerase (Stratagene, La Jolla, CA, USA).
Thapsigargin (TG) induced wild-type
STIM1 oligomerization and clustering. A
similar clustering was seen for all altered
constructs independently of TG treatment.
(B) Quantification of STIM1 YFP clustering
in C2C12 cells in dependence of TG. At
least 100 cells per transfection from three independent experiments were counted and assessed for STIM1 YFP clustering, i.e. for the pres-
ence of massive and area-wide clusters. The total number of counted cells was set to 100%, and the percentage of cells (y axis) containing
clusters is shown as a light gray column. Error bars represent the SD. Wild-type STIM1 YFP barely clustered without TG addition. In
contrast, all altered constructs showed massive clustering independently of TG. The human wild-type and p.Asp76/78Ala STIM1 YPF
constructs were a kind gift from Nicolas Demaurex (University of Geneva, Switzerland). p.Asp76/78Ala is an artificial alteration reported
to constitutively activate STIM1.resulting in STIM1 clustering (Figure 3).18 In contrast to
the wild-type myoblasts, myoblasts transfected with any
of the altered constructs displayed statistically significant
STIM1 clustering independently of thapsigargin, indi-
cating that Ca2þ sensing in the SR was impaired (Figures
3A and 3B). We confirmed this by monitoring the forma-
tion of STIM1 clusters in living cells by time-lapse micros-
copy (Movies S1 and S2). Similar results were obtained
with a STIM1 construct harboring the artificial p.Asp76/
78Ala (c.227A>C; c.233A>C) substitution reported to
constitutively activate STIM1 (Figure S6).19–21 These data
demonstrate a strong impact of the mutations on STIM1
function by the triggering of STIM1 clustering indepen-
dent of Ca2þ-store depletion.
We next investigated the pathological mechanism
underlying the disease and monitored the Ca2þ response
to SOCE in myoblasts established from an individual
affected by the c.251A>G (p.Asp84Gly) mutation. Cells
from individuals with other mutations were not available.
Fluorescence-activated-cell-sorting analysis of myoblasts
incubated with the Indo-1 Ca2þ indicator revealed a signif-
icantly higher basal cytoplasmic Ca2þ level in TAM cells
than in control cells (Figure 4 and Table 2). We also
measured a higher cytoplasmic Ca2þ influx in response
to thapsigargin (2 mM) and subsequent addition of calcium
(2 mM) to the medium in TAM cells. Accordingly, Ca2þ
entry without thapsigargin treatment was also higher in
TAM cells. We then challenged the mechanism regulating
Ca2þ entry with a high extracellular Ca2þ concentration.
Direct addition of 20 mM Ca2þ to cells in Ca2þ-free
medium without prior Ca2þ-store depletion induced
a massive Ca2þ influx in the TAM cells; in contrast, there
was a low gradual increase in control cells. This constitu-
tive activation of SOCE underlines a gain-of-functionThe Americmechanism most likely resulting from the disruption of
the Ca2þ-dependent inactivation of STIM1. The mutants
appeared unable to sense the Ca2þ in the SR lumen and
thereby oligomerized and clustered at the SR plasma-
membrane junctions to constitutively activate CRACs. To
assess the Ca2þ amount in the SR, we treated themyoblasts
with 30 mM caffeine to induce extensive store depletion.
Cytometric analysis showed that more Ca2þ was released
from the SR in TAM cells than in control myoblasts
(Figure S7), demonstrating an increased [Ca2þ] in both
the SR and cytoplasm in TAM cells. It is possible that
tubular aggregates directly arise from abnormal STIM1
clustering. Alternatively, an excess of intraluminal and/or
cytosolic Ca2þ, as measured in TAM myoblasts, could
promote SR-membrane remodeling in vivo.
STIM1 and ORAI1 (MIM 610277) are highly expressed in
skeletal muscle. They are both localized at the skeletal-
muscle triad, a specialized junction between the ER and
the plasma membrane, and mice deficient in STIM1 or
ORAI1 display, among others, myopathic features.17,22,23
Excessive store-operated Ca2þ influx, as in TAMmyoblasts,
has also been observed in myotubes from the mouse
model24,25 of Duchenne muscular dystrophy (DMD
[MIM 310200]) and was sufficient to produce a muscular-
dystrophy phenotype in mice.26 It has furthermore been
demonstrated for slow-channel congenital myasthenic
syndrome (MIM 601462)—which involves the formation
of tubular aggregates—that massive Ca2þ entry, due to
abundant acetylcholine-receptor activity at the neuro-
muscular junction, damages the motor endplate and
thereby induces the pathology.27 These examples and our
investigations suggest that altered Ca2þ homeostasis is
implicated in skeletal-muscle dysfunction and that the
augmented SOCE due to constitutively active STIM1 isan Journal of Human Genetics 92, 271–278, February 7, 2013 275
Figure 4. Impact of the STIM1 p.Asp84Gly Substitution on Ca2þ
Homeostasis in TAM Myoblasts
Myoblasts (1.5 3 106 cells) were harvested and incubated in 1 ml
medium containing Indo-1 (Invitrogen) and physiological Ca2þ
concentrations and were then incubated in nominally Ca2þ-free
Ringer solution. Data analysis was done with FlowJo software.
Cell viability was verified by TO-PRO-3 staining (Invitrogen).
The y axes show the Indo-1 ratio, and the x axes show the time
in seconds.
(A) Cytometric analysis indicated a higher basal [Ca2þ] and an
increased Ca2þ entry after store depletion with TG in myoblasts
from individual II.1 (family 1, p.Asp84Gly).
(B) An increased Ca2þ influx in TAM cells was also seenwithout TG
treatment.
(C) To challenge the mechanisms regulating Ca2þ influx, we
directly added 20 mM Ca2þ without previous Ca2þ-store deple-
tion, resulting in a significantly higher Ca2þ influx in the TAM
myoblasts.the major cause of the TAM phenotype. One of the hall-
marks of DMD is the strongly elevated bloodstream CK
level, which we also noted in all our TAM-affected families.Table 2. Quantification of the Ca2þ Influx in Myoblasts from an Indiv
Cell Line Baseline TG and
Control 1 0.085 5 0.005 0.063 5
Control 2 0.079 5 0.002 0.072 5
Individual II.1 (family 1) 0.126 5 0.007 0.108 5
p value 2.95 3 1013 9.28 3 1
Experiments were carried out with 1.5 3 106 cells and were repeated four times.
276 The American Journal of Human Genetics 92, 271–278, FebruaryCa2þ is known to be implicated in membrane repair in
skeletal muscle.28 As a consequence of the constitutively
active SOCE, cytosolic [Ca2þ] is steadily high, and defects
in both SR structure and Ca2þ homeostasis might explain
the muscle weakness and progressive course of TAM. Pre-
venting excessive extracellular Ca2þ influx could therefore
be a potential therapeutic approach for TAM.
Of note, a mouse line obtained by genome-wide random
mutagenesis and harboring the same STIM1 p.Asp84Gly
substitution as in one of our TAM-affected families dis-
played macrothrombocytopenia and an associated
bleeding disorder, but skeletal muscle was not investi-
gated.29 Blood counts and coagulation tests of all our
TAM-affected families were within normal ranges, and no
families presented with a bleeding disorder (Table S3). In
addition, recessive loss-of-function mutations in STIM1
and ORAI1 were previously reported in children with
severe immune deficiency (MIM 612782 and MIM
612783). The affected individuals displayed additional
neonatal hypotonia and type II fiber atrophy, and Stim1-
knockout mice were reported to have perinatal muscle
hypotrophy and lethality.22,23,30,31 However, none of our
TAM individuals had repetitive infections or hypotonia.
Taken together, these findings emphasize the importance
of STIM1 in blood platelets, T cell activation, and normal
skeletal-muscle structure and function.Supplemental Data
Supplemental Data include seven figures, three tables, and two
movies and can be found with this article online at http://www.
cell.com/AJHG.Acknowledgments
We thank the members of the families for their cooperation and
interest in this study. We also thank Sophie Nicole, Danielle
Chateau, Jean-Paul Leroy, Rana El Dahr, Nicolas Demaurex,
Bernard Jost, Ste´phanie Le Gras, Jean-Francois Pelissier, Se´bastien
Courrier, Vale´rie Biancalana, and Beate Heizmann for material
supply, discussions, and technical assistance. This work was sup-
ported by grants from the Institut National de la Sante´ et de la
RechercheMedicale, Centre National de la Recherche Scientifique,
Universite´ de Strasbourg, Aix-Marseille Universite´, Colle`ge de
France, Agence Nationale de la Recherche (ANR-11-BSV1-026),
Fondation Maladies Rares, Groupement d’Inte´reˆt Scientifique–
Maladies Rares, Association Franc¸aise contre les Myopathies,
Muscular Dystrophy Association, and Myotubular Trust.idual with TAM
2 mM Ca2þ 2 mM Ca2þ 20 mM Ca2þ
0.013 0.014 5 0.005 0.052 5 0.028
0.019 0.031 5 0.004 0.088 5 0.009
0.010 0.043 5 0.006 0.125 5 0.025
04 1.34 3 102 8.02 3 103
The following abbreviation is used: TG, thapsigargin.
7, 2013
Received: September 11, 2012
Revised: October 31, 2012
Accepted: December 14, 2012
Published: January 17, 2013Web Resources
The URLs for data presented herein are as follows:
1000 Genomes, http://www.1000genomes.org/
dbSNP, http://www.ncbi.nlm.nih.gov/SNP/
FlowJo, http://www.treestar.com/
GenBank, http://www.ncbi.nlm.nih.gov/genbank/
NHLBI Exome Sequencing Project Exome Variant Server, http://
evs.gs.washington.edu/EVS/
Online Mendelian Inheritance in Man (OMIM), http://www.
omim.org/
PolyPhen, http://genetics.bwh.harvard.edu/pph/
RefSeq, http://www.ncbi.nlm.nih.gov/RefSeq
SIFT, http://sift.jcvi.org/References
1. Li, Z., Lu, J., Xu, P., Xie, X., Chen, L., and Xu, T. (2007).
Mapping the interacting domains of STIM1 and Orai1 in
Ca2þ release-activated Ca2þ channel activation. J. Biol.
Chem. 282, 29448–29456.
2. Stathopulos, P.B., Zheng, L., Li, G.Y., Plevin, M.J., and Ikura,
M. (2008). Structural and mechanistic insights into STIM1-
mediated initiation of store-operated calcium entry. Cell
135, 110–122.
3. Stathopulos, P.B., Li, G.Y., Plevin, M.J., Ames, J.B., and Ikura,
M. (2006). Stored Ca2þ depletion-induced oligomerization
of stromal interaction molecule 1 (STIM1) via the EF-SAM
region: An initiation mechanism for capacitive Ca2þ entry.
J. Biol. Chem. 281, 35855–35862.
4. Luik, R.M., Wu, M.M., Buchanan, J., and Lewis, R.S. (2006).
The elementary unit of store-operated Ca2þ entry: Local acti-
vation of CRAC channels by STIM1 at ER-plasma membrane
junctions. J. Cell Biol. 174, 815–825.
5. Park, C.Y., Hoover, P.J., Mullins, F.M., Bachhawat, P., Coving-
ton, E.D., Raunser, S., Walz, T., Garcia, K.C., Dolmetsch, R.E.,
and Lewis, R.S. (2009). STIM1 clusters and activates CRAC
channels via direct binding of a cytosolic domain to Orai1.
Cell 136, 876–890.
6. Putney, J.W. (2010). Pharmacology of store-operated calcium
channels. Mol. Interv. 10, 209–218.
7. Wu, M.M., Buchanan, J., Luik, R.M., and Lewis, R.S. (2006).
Ca2þ store depletion causes STIM1 to accumulate in ER
regions closely associated with the plasma membrane. J. Cell
Biol. 174, 803–813.
8. Chevessier, F., Bauche´-Godard, S., Leroy, J.P., Koenig, J., Patur-
neau-Jouas, M., Eymard, B., Hantaı¨, D., and Verdie`re-Sahuque´,
M. (2005). The origin of tubular aggregates in human myopa-
thies. J. Pathol. 207, 313–323.
9. Boncompagni, S., Protasi, F., and Franzini-Armstrong, C.
(2012). Sequential stages in the age-dependent gradual forma-
tion and accumulation of tubular aggregates in fast twitch
muscle fibers: SERCA and calsequestrin involvement. Age
(Dordr.) 34, 27–41.
10. Engel, W.K., Bishop, D.W., and Cunningham, G.G. (1970).
Tubular aggregates in type II muscle fibers: UltrastructuralThe Americand histochemical correlation. J. Ultrastruct. Res. 31,
507–525.
11. Mu¨ller, H.D., Vielhaber, S., Brunn, A., and Schro¨der, J.M.
(2001). Dominantly inherited myopathy with novel tubular
aggregates containing 1-21 tubulofilamentous structures.
Acta Neuropathol. 102, 27–35.
12. Schiaffino, S. (2012). Tubular aggregates in skeletal muscle:
Just a special type of protein aggregates? Neuromuscul.
Disord. 22, 199–207.
13. Li, H., and Durbin, R. (2009). Fast and accurate short read
alignment with Burrows-Wheeler transform. Bioinformatics
25, 1754–1760.
14. Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer,
N., Marth, G., Abecasis, G., and Durbin, R.; 1000 Genome
Project Data Processing Subgroup. (2009). The Sequence
Alignment/Map format and SAMtools. Bioinformatics 25,
2078–2079.
15. Ng, P.C., and Henikoff, S. (2003). SIFT: Predicting amino acid
changes that affect protein function. Nucleic Acids Res. 31,
3812–3814.
16. Ramensky, V., Bork, P., and Sunyaev, S. (2002). Human non-
synonymous SNPs: Server and survey. Nucleic Acids Res. 30,
3894–3900.
17. Kiviluoto, S., Decuypere, J.P., De Smedt, H., Missiaen, L., Parys,
J.B., and Bultynck, G. (2011). STIM1 as a key regulator for
Ca2þ homeostasis in skeletal-muscle development and func-
tion. Skelet Muscle 1, 16.
18. Liou, J., Kim, M.L., Heo, W.D., Jones, J.T., Myers, J.W., Ferrell,
J.E., Jr., and Meyer, T. (2005). STIM is a Ca2þ sensor essential
for Ca2þ-store-depletion-triggered Ca2þ influx. Curr. Biol. 15,
1235–1241.
19. Zhang, S.L., Yu, Y., Roos, J., Kozak, J.A., Deerinck, T.J.,
Ellisman, M.H., Stauderman, K.A., and Cahalan, M.D.
(2005). STIM1 is a Ca2þ sensor that activates CRAC channels
and migrates from the Ca2þ store to the plasma membrane.
Nature 437, 902–905.
20. Mercer, J.C., Dehaven, W.I., Smyth, J.T., Wedel, B., Boyles,
R.R., Bird, G.S., and Putney, J.W., Jr. (2006). Large store-oper-
ated calcium selective currents due to co-expression of Orai1
or Orai2 with the intracellular calcium sensor, Stim1. J. Biol.
Chem. 281, 24979–24990.
21. Smyth, J.T., Dehaven, W.I., Bird, G.S., and Putney, J.W., Jr.
(2008). Ca2þ-store-dependent and -independent reversal of
Stim1 localization and function. J. Cell Sci. 121, 762–772.
22. McCarl, C.A., Picard, C., Khalil, S., Kawasaki, T., Ro¨ther, J.,
Papolos, A., Kutok, J., Hivroz, C., Ledeist, F., Plogmann, K.,
et al. (2009). ORAI1 deficiency and lack of store-operated
Ca2þ entry cause immunodeficiency, myopathy, and
ectodermal dysplasia. J. Allergy Clin. Immunol. 124, 1311–
1318, e7.
23. Stiber, J., Hawkins, A., Zhang, Z.S., Wang, S., Burch, J., Gra-
ham, V., Ward, C.C., Seth, M., Finch, E., Malouf, N., et al.
(2008). STIM1 signalling controls store-operated calcium
entry required for development and contractile function in
skeletal muscle. Nat. Cell Biol. 10, 688–697.
24. Boittin, F.X., Petermann, O., Hirn, C., Mittaud, P., Dorchies,
O.M., Roulet, E., and Ruegg, U.T. (2006). Ca2þ-independent
phospholipase A2 enhances store-operated Ca2þ entry
in dystrophic skeletal muscle fibers. J. Cell Sci. 119, 3733–
3742.
25. Edwards, J.N., Friedrich, O., Cully, T.R., von Wegner, F.,
Murphy, R.M., and Launikonis, B.S. (2010). Upregulation ofan Journal of Human Genetics 92, 271–278, February 7, 2013 277
store-operated Ca2þ entry in dystrophic mdx mouse muscle.
Am. J. Physiol. Cell Physiol. 299, C42–C50.
26. Millay, D.P., Goonasekera, S.A., Sargent, M.A., Maillet, M.,
Aronow, B.J., and Molkentin, J.D. (2009). Calcium influx is
sufficient to induce muscular dystrophy through a TRPC-
dependent mechanism. Proc. Natl. Acad. Sci. USA 106,
19023–19028.
27. Engel, A.G., Lambert, E.H., Mulder, D.M., Torres, C.F., Sahashi,
K., Bertorini, T.E., and Whitaker, J.N. (1982). A newly recog-
nized congenital myasthenic syndrome attributed to a pro-
longed open time of the acetylcholine-induced ion channel.
Ann. Neurol. 11, 553–569.
28. Idone, V., Tam, C., and Andrews, N.W. (2008). Two-way traffic
on the road to plasma membrane repair. Trends Cell Biol. 18,
552–559.278 The American Journal of Human Genetics 92, 271–278, February29. Grosse, J., Braun, A., Varga-Szabo, D., Beyersdorf, N.,
Schneider, B., Zeitlmann, L., Hanke, P., Schropp, P., Mu¨hlstedt,
S., Zorn, C., et al. (2007). An EF handmutation in Stim1 causes
premature platelet activation and bleeding in mice. J. Clin.
Invest. 117, 3540–3550.
30. Feske, S., Gwack, Y., Prakriya, M., Srikanth, S., Puppel, S.H.,
Tanasa, B., Hogan, P.G., Lewis, R.S., Daly, M., and Rao, A.
(2006). A mutation in Orai1 causes immune deficiency by
abrogating CRAC channel function. Nature 441, 179–185.
31. Picard, C., McCarl, C.A., Papolos, A., Khalil, S., Lu¨thy, K.,
Hivroz, C., LeDeist, F., Rieux-Laucat, F., Rechavi, G., Rao, A.,
et al. (2009). STIM1 mutation associated with a syndrome of
immunodeficiency and autoimmunity. N. Engl. J. Med. 360,
1971–1980.7, 2013
